Beijing Wehand-bio Pharmaceutical Co.
Latest round
- Series B
Last raised
- Jan 2017
Total raised
- $4.9M
Investors
- 4
About Beijing Wehand-bio Pharmaceutical Co.
,Ltd focuses on developing and manufacturing medicine for curing diabetes mellitus, tumor and cardiovascular disease.
Who invested in Beijing Wehand-bio Pharmaceutical Co.
4 investors across 3 rounds
See all investors in Beijing Wehand-bio Pharmaceutical Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Beijing Wehand-bio Pharmaceutical Co.
Who invested in Beijing Wehand-bio Pharmaceutical Co.?
Beijing Wehand-bio Pharmaceutical Co. has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Beijing Wehand-bio Pharmaceutical Co. raised?
Beijing Wehand-bio Pharmaceutical Co. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Beijing Wehand-bio Pharmaceutical Co. last raise money?
Beijing Wehand-bio Pharmaceutical Co.'s most recent round on record is a Series B, in Jan 2017.
What does Beijing Wehand-bio Pharmaceutical Co. do?
,Ltd focuses on developing and manufacturing medicine for curing diabetes mellitus, tumor and cardiovascular disease.
Where is Beijing Wehand-bio Pharmaceutical Co. headquartered?
Beijing Wehand-bio Pharmaceutical Co. is headquartered in Beijing, China.
Which VCs invest in companies like Beijing Wehand-bio Pharmaceutical Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Beijing Wehand-bio Pharmaceutical Co.'s stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Beijing Wehand-bio Pharmaceutical Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.